Zacks: Brokerages Anticipate Express Scripts Holding Company (ESRX) Will Post Quarterly Sales of $25.77 Billion
Wall Street brokerages forecast that Express Scripts Holding Company (NASDAQ:ESRX) will post sales of $25.77 billion for the current quarter, Zacks reports. Nine analysts have provided estimates for Express Scripts Holding’s earnings, with the lowest sales estimate coming in at $25.34 billion and the highest estimate coming in at $26.77 billion. Express Scripts Holding reported sales of $25.41 billion during the same quarter last year, which indicates a positive year over year growth rate of 1.4%. The firm is scheduled to report its next earnings results on Tuesday, October 24th.
According to Zacks, analysts expect that Express Scripts Holding will report full year sales of $25.77 billion for the current financial year, with estimates ranging from $99.99 billion to $103.96 billion. For the next financial year, analysts expect that the firm will report sales of $103.75 billion per share, with estimates ranging from $100.40 billion to $106.85 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Express Scripts Holding.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.02. The company had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business’s revenue was up .5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.57 EPS.
ESRX has been the topic of a number of research reports. ValuEngine lowered shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Mizuho cut their target price on shares of Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 25th. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a research note on Friday, July 21st. They set a “hold” rating on the stock. Cowen and Company reaffirmed an “outperform” rating and set a $83.00 target price on shares of Express Scripts Holding in a research note on Friday, June 9th. Finally, Evercore ISI cut their target price on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 26th. Four analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $70.81.
In other Express Scripts Holding news, VP Phyllis S. Anderson sold 1,100 shares of Express Scripts Holding stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the transaction, the vice president now directly owns 11,108 shares of the company’s stock, valued at $667,368.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.68% of the stock is currently owned by insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Pzena Investment Management LLC purchased a new position in shares of Express Scripts Holding during the second quarter valued at about $181,234,000. Old Mutual Global Investors UK Ltd. boosted its position in shares of Express Scripts Holding by 311.4% in the first quarter. Old Mutual Global Investors UK Ltd. now owns 2,157,210 shares of the company’s stock valued at $142,181,000 after buying an additional 1,632,801 shares during the period. Renaissance Technologies LLC boosted its position in shares of Express Scripts Holding by 9,353.3% in the first quarter. Renaissance Technologies LLC now owns 1,308,239 shares of the company’s stock valued at $86,226,000 after buying an additional 1,294,400 shares during the period. Baupost Group LLC MA purchased a new position in shares of Express Scripts Holding during the first quarter valued at about $80,978,000. Finally, Veritas Asset Management LLP boosted its position in shares of Express Scripts Holding by 13.2% in the second quarter. Veritas Asset Management LLP now owns 8,192,572 shares of the company’s stock valued at $523,014,000 after buying an additional 952,249 shares during the period. 90.20% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Zacks: Brokerages Anticipate Express Scripts Holding Company (ESRX) Will Post Quarterly Sales of $25.77 Billion” was posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/zacks-brokerages-anticipate-express-scripts-holding-company-esrx-will-post-quarterly-sales-of-25-77-billion/1469972.html.
Express Scripts Holding (NASDAQ ESRX) traded down 1.005% during trading on Thursday, hitting $60.585. 2,540,307 shares of the stock were exchanged. The stock has a market cap of $34.99 billion, a P/E ratio of 10.515 and a beta of 0.90. Express Scripts Holding has a 52 week low of $57.80 and a 52 week high of $77.61. The stock has a 50 day moving average of $62.96 and a 200-day moving average of $64.58.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.